Overview
Natalizumab, sold under the brand name Tysabri, is a prescription medication approved by the Food and Drug Administration (FDA) for treating adults with multiple sclerosis (MS). Natalizumab is not a cure for… read more
Overview
Tyruko is approved by the U.S. Food and Drug Administration (FDA) as a monotherapy for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting…
read moreOverview
Tysabri is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (MS). Tysabri is also known by its drug name,… read more